Clinical Trial Detail

NCT ID NCT03954704
Title Study of GS-1423 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Advanced Solid Tumor

Therapies

Fluorouracil + GS-1423 + Leucovorin + Oxaliplatin

GS-1423

Age Groups: adult senior

No variant requirements are available.